For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241115:nRSO4304Ma&default-theme=true
RNS Number : 4304M Cambridge Nutritional Sciences PLC 15 November 2024
15 November 2024
Cambridge Nutritional Sciences plc
(the "Company" or "CNSL")
Notice of Results and Investor Presentation
Cambridge Nutritional Sciences plc (AIM:CNSL), the specialist medical
diagnostics company focused on promoting a personalised and functional
approach to health and nutrition, confirms it will issue its Half Year results
for the six months ended 30 September 2023 on Thursday 21 November 2024.
Investor presentation
There will be a live presentation relating to the Half Year Results via the
Investor Meet Company platform on Thursday 21 November 2024 at 16:00 GMT.
The presentation is open to all existing and potential shareholders. Questions
can be submitted pre-event via your Investor Meet Company dashboard up until
20 Nov 2024, 09:00 GMT, or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet
Cambridge Nutritional Sciences plc via:
https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register-investor
(https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register-investor)
Investors who already follow Cambridge Nutritional Sciences plc on the
Investor Meet Company platform will automatically be invited.
Contacts:
Cambridge Nutritional Sciences plc www.cnsplc.com (http://www.cnsplc.com)
Carolyn Rand, Executive Chair investors@cnsplc.com
James Cooper, Interim Chief Executive
Cavendish Capital Markets Limited Tel: 020 7220 0500
Geoff Nash / Edward Whiley / (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical
diagnostics company focused on promoting a personalised and functional
approach to health and nutrition.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NORFFDSUIELSEEF